Literature DB >> 235539

The reaction of N-ethylmaleimide at the active site of succinate dehydrogenase.

W C Kenney.   

Abstract

Since 1938 mammalian succinate dehydrogenase has been thought to contain thiol groups at the active site. This hypothesis was questioned recently, because irreversible inhibition by bromopyruvate and N-ethylmaleimide appeared not to satisfy the requisite criteria for reaction at the active site. These recent observations of incomplete inactivation of succinate dehydrogenase by N-ethylmaleimide and incomplete protection by substrates can, however, be explained adequately by the presence of oxalacetate and other strong competitors of the inactivation process in the enzyme used in these studies. Substrates, competitive inhibitors, and anions which activate succinate dehydrogenase protect the enzyme from inhibition by N-ethylmaleimide. Inhibition of succinate dehydrogenase by N-ethylmaleimide involves at least two second order reactions which are pH dependent, with pKa values of 8.0 to 8.2. This pH dependence, the known reactivity of N-ethylmaleimide toward thiols, and the protection by substrate and competitive inhibitors indicate that sulfhydryl residues are required for catalytic activity and perform an essential, not secondary, role in the catalysis. Just as the presence of tightly bound oxalacetate prevents inhibition by N-ethylmaleimide, alkylation of the sulfhydryl residue(s) at the active site prevents the binding of [14C]oxalacetate. Thus, these thiol groups at the active site also may be the site of tight binding of oxalacetate during the activation-deactivation cycle.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235539

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Mechanisms of the interaction of nitroxyl with mitochondria.

Authors:  Sruti Shiva; Jack H Crawford; Anup Ramachandran; Erin K Ceaser; Tess Hillson; Paul S Brookes; Rakesh P Patel; Victor M Darley-Usmar
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 2.  Catalytic mechanisms of complex II enzymes: a structural perspective.

Authors:  T M Iverson
Journal:  Biochim Biophys Acta       Date:  2012-09-18

3.  Study of the interaction of cadmium with membrane-bound succinate dehydrogenase.

Authors:  D Jay; R Zamorano; E Muñoz; R Gleason; J L Boldu
Journal:  J Bioenerg Biomembr       Date:  1991-04       Impact factor: 2.945

4.  Inhibition of membrane-bound succinate dehydrogenase by disulfiram.

Authors:  D Jay
Journal:  J Bioenerg Biomembr       Date:  1991-04       Impact factor: 2.945

5.  Modulation of mitochondrial succinate dehydrogenase activity, mechanism and function.

Authors:  M Gutman
Journal:  Mol Cell Biochem       Date:  1978-06-15       Impact factor: 3.396

6.  The use of amphipathic maleimides to study membrane-associated proteins.

Authors:  D G Griffiths; M D Partis; P Churchill; S C Brenner; S Fleischer; R J Moore; R B Beechey
Journal:  J Bioenerg Biomembr       Date:  1990-10       Impact factor: 2.945

7.  New properties of Bacillus subtilis succinate dehydrogenase altered at the active site. The apparent active site thiol of succinate oxidoreductases is dispensable for succinate oxidation.

Authors:  L Hederstedt; L O Hedén
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

8.  Computationally modeling mammalian succinate dehydrogenase kinetics identifies the origins and primary determinants of ROS production.

Authors:  Neeraj Manhas; Quynh V Duong; Pilhwa Lee; Joshua D Richardson; John D Robertson; Michael A Moxley; Jason N Bazil
Journal:  J Biol Chem       Date:  2020-08-28       Impact factor: 5.157

9.  Inhibition of membrane-bound succinate dehydrogenase by fluorescamine.

Authors:  D Jay; E G Jay; C Garcia
Journal:  J Bioenerg Biomembr       Date:  1993-12       Impact factor: 2.945

10.  Possible occurrence and role of an essential histidyl residue in succinate dehydrogenase.

Authors:  S B Vik; Y Hatefi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.